DiaMedica Therapeutics Inc. (DMAC)
NASDAQ · Healthcare
DiaMedica Therapeutics Inc. Revenue 2018–2018
DiaMedica Therapeutics Inc. annual/quarterly revenue history and growth rate from 2018 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- DiaMedica Therapeutics Inc. revenue for the quarter ending September 30, 2018 was 500000.
- DiaMedica Therapeutics Inc. annual revenue for 2018 was 500000.
Revenue
QUARTERLY · $B
DiaMedica Therapeutics Inc. Market Cap — FAQ
DiaMedica Therapeutics Inc. (DMAC) market cap over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DMAC's market cap history?
The chart and table above show DiaMedica Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.